Cell Point (India) Limited

As of March 31, 2026, Cell Point (India) Limited carries a market capitalization of 224.23M, placing it among publicly traded companies globally. Its enterprise value stands at 950.99M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Cell Point (India) Limited has 18.69M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Cell Point (India) Limited maintains a current ratio of 1.36, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Cell Point (India) Limited's stock has declined approximately 3.75% over the past 52 weeks. The 50-day moving average sits at 16.05, while the 200-day moving average is 16.15.

As of March 31, 2026, Cell Point (India) Limited holds 44.31M in cash and equivalents against 771.07M in total debt, resulting in a net debt position of 726.77M. Total book value stands at 743.17M, with working capital of 228.89M providing operational flexibility.